3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Kidney transplantees face higher melanoma risk

CancerSep 26, 05

People who’ve undergone a kidney transplant have an increased risk of developing melanoma, according to a new report.

“There is evidence from previous studies that the immunosuppression regimen (used after a kidney transplant) affects the risk of melanoma,” Dr. Christopher S. Hollenbeak told Reuters Health. “We are currently working to identify specific regimens in the United States Renal Data System (USRDS) data in order to determine whether risk is associated with specific agents.”

Hollenbeak, from Penn State College of Medicine in Hershey, Pennsylvania, and his associates used data from the USRDS and another national database to compare the occurrence of melanoma among kidney transplant recipients with that reported in the general population.

The melanoma rate in kidney recipients was 3.6 times that in the general population, the team reports in the medical journal Cancer.

The risk was 3.8 times higher in men, 1.9 times higher in women, and more than 17 times higher in African Americans, the report indicates.

In men, but not women, the risk of melanoma increased with age, both in the transplant population and in the general population, the researchers note.

“I would hope that physicians would understand that the risk of melanoma is increased in kidney transplant recipients, particularly among men and African Americans,” Hollenbeak said. “These patients need to be educated about their risk and how to perform a self examination.”

Also, he advised, “follow-up care should be coordinated with a dermatologist and include routine skin examinations.”

SOURCE: Cancer, online September 26, 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site